Home › COPD › Indiana › Hammond
COPD clinical trials in Hammond, IN
3 studies for COPD are looking for participants at sites in and around Hammond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RecruitingPhase 3
- Asha Clinical Research - Munster- Site Number : 8400115, Hammond
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RecruitingPhase 2/3
- ASHA Clinical Research - Munster, LLC, Hammond
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
RecruitingPhase 3
- Research Site, Munster · 1 mi away
About COPD
COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.
More about COPD on MedlinePlus
COPD trials in other cities
- Philadelphia, PA26 studies
- Miami, FL20 studies
- Houston, TX18 studies
- Birmingham, AL17 studies
- Baltimore, MD16 studies
- Boston, MA15 studies
- Orlando, FL15 studies
- Chicago, IL15 studies
- Dallas, TX13 studies
- New York City, NY12 studies
- Pittsburgh, PA11 studies
- Winston-Salem, NC11 studies
Other studies in Hammond
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer11 studies
- Breast Cancer9 studies
- Heart Failure8 studies
- Ovarian Cancer5 studies
- High Blood Pressure4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Colorectal Cancer4 studies
- Colon Cancer4 studies
- Blood Clots4 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.